Knight Therapeutics Inc. GUD.TO
TSX
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 11.61M | 10.77M | 4.08M | -4.00M | -2.68M |
| Total Depreciation and Amortization | 44.31M | 45.66M | 43.59M | 39.86M | 39.06M |
| Total Amortization of Deferred Charges | 705.10K | 705.10K | 705.10K | 705.10K | 662.90K |
| Total Other Non-Cash Items | 21.39M | 18.88M | 12.76M | 11.46M | 4.22M |
| Change in Net Operating Assets | 16.64M | 7.37M | 15.57M | 1.57M | -15.63M |
| Cash from Operations | 94.66M | 83.39M | 76.70M | 49.59M | 25.62M |
| Capital Expenditure | -3.46M | -3.53M | -3.53M | -1.37M | -1.41M |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 0.00 | 20.90K | 92.30K |
| Cash Acquisitions | -6.10M | -8.42M | -79.57M | -79.57M | -79.57M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 12.68M | 11.69M | 13.23M | 25.78M | 41.93M |
| Cash from Investing | 3.11M | -265.70K | -69.88M | -55.14M | -38.95M |
| Total Debt Issued | 867.00K | 867.00K | 110.26M | 112.07M | 111.75M |
| Total Debt Repaid | -83.41M | -85.78M | -103.27M | -93.44M | -71.56M |
| Issuance of Common Stock | 1.58M | 1.02M | 734.00K | 736.00K | 743.00K |
| Repurchase of Common Stock | -12.28M | -12.28M | -11.24M | -6.35M | -8.50M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.84M | -6.56M | -7.68M | -7.60M | -7.57M |
| Cash from Financing | -71.52M | -74.20M | -8.06M | 4.20M | 18.19M |
| Foreign Exchange rate Adjustments | 1.85M | 2.68M | -1.49M | -2.08M | 135.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 28.10M | 11.61M | -2.73M | -3.43M | 5.00M |